MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$4,986,614
EPS
-$0.15
Unit: Dollar
Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development
2,669,779
-3,770,856.5*
14,521,342
2,569,943
General and administrative expenses
2,406,587
2,140,941.5*
1,287,783
1,353,172
Total operating expenses
5,076,366
-1,629,915
15,809,125
3,923,115
Gain from operations
-5,076,366
1,629,915*
-15,809,125
-3,923,115
Loss on debt conversion with related party
-
-7,078,664.75*
-
-
Loss on fixed asset disposal
-
-682.75*
-
-
Sublease income
19,455
-
-
-
Interest income (expense), net
77,350
-191,003.5*
80,582
111,379
Exchange loss, net
-5,860
-8,450.5*
-17,509
4,532
Total other income (expense)
90,945
-7,278,801.5*
63,073
115,911
Loss before income taxes
-4,985,421
-5,648,886.5*
-15,746,052
-3,807,204
Deferred income tax expense
1,193
223,026.5*
-1,436
149
Net loss
-4,986,614
-5,871,913*
-15,744,616
-3,807,353
Accrual of paid-in-kind dividends on series a non-voting convertible preferred stock
-
-314,165.5*
-
-
Net loss attributable to common stockholders
-4,986,614
-6,186,078.5
-15,744,616
-3,807,353
Basic EPS
-0.15
-0.557
-8.2
-1.99
Diluted EPS
-0.15
-0.557
-8.2
-1.99
Basic Average Shares
33,544,748
11,101,777
1,919,433
1,911,128
Diluted Average Shares
33,544,748
11,101,777
1,919,433
1,911,128
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net lossattributable to common...-$4,986,614 Net loss-$4,986,614 Interest income(expense), net$77,350 Sublease income$19,455 Loss before incometaxes-$4,985,421 Deferred income taxexpense$1,193 Total other income(expense)$90,945 Exchange loss, net-$5,860 Gain from operations-$5,076,366 Total operatingexpenses$5,076,366 Research and development$2,669,779 General andadministrative expenses$2,406,587

Dogwood Therapeutics, Inc. (DWTX)

Dogwood Therapeutics, Inc. (DWTX)